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ABSTRACT
Motivation: The ability of human immunodeficiency virus-1 (HIV-1)
protease to develop mutations that confer multi-drug resistance
(MDR) has been a major obstacle in designing rational therapies
against HIV. Resistance is usually imparted by a cooperative
mechanism that can be elucidated by a covariance analysis of
sequence data. Identification of such correlated substitutions of
amino acids may be obscured by evolutionary noise.
Results: HIV-1 protease sequences from patients subjected to
different specific treatments (set 1), and from untreated patients
(set 2) were subjected to sequence covariance analysis by evaluat-
ing the mutual information (MI) between all residue pairs. Spectral
clustering of the resulting covariance matrices disclosed two
distinctive clusters of correlated residues: the first, observed in set
1 but absent in set 2, contained residues involved in MDR
acquisition; and the second, included those residues differentiated
in the various HIV-1 protease subtypes, shortly referred to as the
phylogenetic cluster. The MDR cluster occupies sites close to the
central symmetry axis of the enzyme, which overlap with the global
hinge region identified from coarse-grained normal-mode analysis
of the enzyme structure. The phylogenetic cluster, on the other hand,
occupies solvent-exposed and highly mobile regions. This study
demonstrates (i) the possibility of distinguishing between the
correlated substitutions resulting from neutral mutations and those
induced by MDR upon appropriate clustering analysis of sequence
covariance data and (ii) a connection between global dynamics and
functional substitution of amino acids.
Contact: bahar@ccbb.pitt.edu
Supplementary information: Supplementary data are available at
Bioinformatics online.
1 INTRODUCTION
HIV-1 protease plays an important role in the late stage of
viral replication by cleavage of premature viral polypeptides
to peptides that fold into mature virus proteins. The ability
of HIV-1 protease to rapidly acquire a variety of mutants
in response to various protease inhibitors (PI) confers the
enzyme with high resistance to anti-AIDS treatments. A high
cooperativity has been documented among drug-resistant
mutations observed in HIV-1 protease (Ohtaka et al., 2003).
The sequence data retrieved from treated patients is likely to
include mutations that reflect cooperative effects originating
from late functional constraints, rather than stochastic evolu-
tionary noise (Atchley et al., 2000). Extensive studies have been
made on this protein structure and dynamics (Cecconi et al.,
2001; Hornak et al., 2006; Perryman et al., 2004; Zoete et al.,
2002) although the molecular mechanisms of multi-drug
resistance (MDR) is yet to be elucidated.
HIV-1 protease is particularly suitable for covariance
analysis because of the large sets of sequences available, and
the observed fast rate of mutations in response to treatments.
Sequence covariance analysis is a method widely used for
identifying correlated sites in proteins. Such correlations are
usually inferred from the statistical analysis of pairwise amino-
acid substitutions among the members of the examined family
of proteins. Because correlated substitutions are expected
to occur between residue pairs directly interacting in the
3-dimensional (3D) structure, sequence covariance analysis,
also referred to as correlated mutation analysis (CMA), has
long been used for detecting inter-residue contacts within
proteins (Eyal et al., 2007a, b; Gobel et al., 1994; Olmea et al.,
1999; Shindyalov et al., 1994; Thomas et al., 1996). More
recently, the same approach proved useful in identifying
communication pathways in allosteric proteins (Hatley et al.,
2003; Kass and Horovitz, 2002; Lockless and Ranganathan,
1999; Shulman et al., 2004; Su ¨ el et al., 2003), and in studying
drug-induced mutations using clinical data (Hoffman et al.,
2003; Wu et al., 2003).
The CMA procedure consists of three steps, in general:
(i) generation of multiple sequence alignment (MSA) using
homologous protein sequences; (ii) quantifying the covari-
ance between different columns in MSA and (iii) identifying
groups of highly covariant positions, also called clustering. The
underlying assumption is that co-varying residues reflect essen-
tial structural/functional inter-residue couplings.
These techniques have some major limitations. The purpose
of the method is to identify inter-residue couplings that are
directly relevant to protein structure or function. However,
the observed signals may not solely arise from such couplings.
In fact sequence data are known to be noisy. A strong covari-
ance may be detected among columns due to evolutionary
signals that originate from early random mutation events.
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residue interactions is comparable in magnitude to the noise
caused by other stochastic evolutionary events.
Several metrics have been used to quantify sequence
covariance in proteins. A comparative analysis of some com-
monly used methods can be found in the studies of Fodor and
Aldrich (2004) and Halperin et al. (2006). Yet, not enough
attention has been given to date, to the clustering step. This step
is important due to various reasons. First, although the CMA is
performed in a pairwise manner (mainly due to technical and
statistical reasons), it is clear that in nature larger sets of
residues are expected to co-evolve to meet particular structural/
functional requirements. Second, the clustering procedure is
expected to help in distinguishing the real correlations from the
background noise. The choice of clustering technique may also
depend on the adopted CMA. When an asymmetric metric
like the statistical coupling analysis (SCA) introduced by
Ranganathan and coworkers (Lockless and Ranganathan,
1999) is used in step 2, a hierarchical clustering is conveniently
applied (Chen et al., 2006; Hatley et al., 2003; Shulman et al.,
2004; Su ¨ el et al., 2003). For symmetric metrics such as Pearson
correlation coefficient and MI, on the other hand, a common
procedure is to perform a principal component analysis (Wold
et al., 1987; Fleishman et al., 2001).
We adopt the MI content as a measure of the correlation
between residue substitutions (Atchley et al., 2000; Clarke,
1995; Hoffman et al., 2003; Martin et al., 2005). Accordingly,
each of the N columns in the MSA generated for a protein
of N residues is considered as a discrete random variable
Xi (1 i N) that takes on one of the 20 amino-acid types
with some probability. The MI (Cover and Thomas, 1991)
associated with the random variables Xi and Xj corresponding
to the ith and jth columns is defined as
IðXi,XjÞ¼
X
allxi
X
allxj
PðXi ¼ xi,Xj ¼ xjÞlog
PðXi ¼ xi,Xj ¼ xjÞ
PðXi ¼ xiÞPðXj ¼ xjÞ
ð1Þ
Here P(Xi¼xi, Xj¼xj) is the joint probability of occurrence
of amino-acid types xi and xj at the ith and jth positions,
respectively, P(Xi¼xi) and P(Xj¼xj) are the corresponding
singlet probabilities. I(Xi, Xj) is the ijth element of the N N
MI matrix I corresponding to the examined MSA.
In the present study, we introduce the use of spectral
partitioning methods for efficient analysis of the MI matrices
derived for HIV-1 protease sequences retrieved from the
Stanford HIV Drug Resistance database (DB) (http://hivdb.
stanford.edu; Rhee et al., 2003) (Table 1). This DB includes
sequences obtained from isolates along with information on the
type of PIs given to the patients (accessible via the ‘Detailed
Treatment Queries’ interface of the DB). The goal is to examine
sequence co-variance and distinguish between correlations
of different origin. Spectral clustering was originally proposed
for partitioning the nodes in an undirected weighted graph
G¼(V,E). The weight wij of each edge eij is defined as a
measure of similarity between nodes vi and vj. This weight
matrix W is replaced in our work by the MI matrix. Our
objective will be to partition all the nodes/residues into groups,
such that the similarity is high among the nodes within a group
and low across different groups. This goal will be achieved by
minimizing the normalized cut (Shi and Malik, 2000) between
groups (see Materials and Methods).
We show that the method successfully identifies the resi-
dues cooperatively involved in MDR, as well as the mutational
patterns arising from different drug treatments. The results
suggest that spectral partitioning of the covariance data can
help in detecting cooperative functional relations and discrimi-
nating to a certain degree between the covariance patterns
originating from functional constraints and those associated
with neutral/stochastic mutation events that occur early in the
evolution of the species/family.
2 METHODS
2.1 Mutual information
Mutual information [MI; Equation (1)] describes the mutual depen-
dence of the two random variables Xi, Xj, it can alternatively be
expressed as
IðXi,XjÞ¼SðXiÞþSðXjÞ SðXi,XjÞ¼SðXiÞ SðXijXjÞð 2Þ
where
SðXiÞ¼ 
X
allxi
PðXi ¼ xiÞlogPðXi ¼ xiÞð 3Þ
is the entropy of Xi,
SX ijXj
  
¼ 
X
allxi
X
allxj
PX i ¼ xi,Xj ¼ xj
  
logPX i ¼ xijXj ¼ xj
  
ð4Þ
is the conditional entropy of Xi given Xj, S(Xi, Xj) is the joint entropy
of Xi and Xj. Equation (2) implies that MI is non-negative. The
non-negativity of MI permits us to use it in the similarity matrix for
spectral clustering.
2.2 Spectral graph partitioning
The normalized cut for two disjoint sets of nodes A and B is defined as
NcutðA,BÞ¼
cutðA,BÞ
assocðA,VÞ
þ
cutðA,BÞ
assocðB,VÞ
: ð5Þ
where cut(A,B) is the total weight of edges connecting the nodes in
A and B,
cutðA,BÞ¼
X
vi2A,vj2B
wij
Table 1. Summary of Data
Dataset Treatment Number of sequences
1 Treated 7758
2 Untreated 8761
3 IDV only 1112
4 IDV þ 2569
5 NFV only 885
6 NFV þ 2131
In the ‘Treatment’ column, ‘treated’ means at least one PI is used in the treatment.
‘IDV þ’ and ‘NFV þ’ means that at least one of the other PIs has been used
in combination with the one before the ‘þ’ sign. IDV and NFV are the respective
PI drugs indinavir and nelfinavir.
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in the graph. Shi and Malik (2000) have derived an algorithm
to approximately solve the optimization problem of minimizing
Ncut(A,B). By adopting a solution for the discrete clustering problem
in a continuous space, the problem reduces to solving the generalized
eigenvalue problem
ðD   WÞy ¼  Dy: ð6Þ
where W¼{wij} is the matrix of the edge weights, also called similarity
or affinity matrix, D is the diagonal matrix with elements, di¼ j wij.
  and y are the generalized eigenvalues and eigenvectors of W,
respectively. The difference D W, also called the Laplacian matrix,
is symmetric and positive semi-definite (Chung, 1997). In order to
partition a graph of N nodes into k clusters, we utilize the first k
eigenvectors y1,...,yk. For the particular case of bi-partitioning the
graph (i.e. k¼2), y2 becomes the only eigenvector used as a criterion,
since  1¼0. In our application, each column in the MSA corresponds
to a residue, which in turn is represented as a node in the graph. The MI
matrix I replaces W, and the graph (protein) is bi-partitioned based
on the elements of y2 (see below).
2.3 k-way clustering
We also performed k-way partitioning of the data using k¼3, 4 and 5.
Dataset 1 was chosen for these additional calculations, as the largest
dataset that contains data about viruses exposed to PIs. We used the
city block distance in k-means clustering. For each k we performed
ten runs, and reported the results for the one with the minimum point-
to-centroid distance sums.
2.4 Protein dynamics
The Gaussian Network Model (GNM) was applied according to the
standard protocol (Yang et al., 2006). We used a cutoff distance of
7.3A ˚ between C
  atoms to define the Kirchhoff matrix of inter-residue
contacts. Details on the methodology may be found in our earlier work
(Bahar et al., 1997; Haliloglu et al., 1997) and recent reviews (Rader
et al., 2006).
3 RESULTS AND DISCUSSION
3.1 Spectral clustering of CMA results
To investigate the correlation between drug treatment and
mutational patterns, we compiled six datasets of sequences,
summarized in Table 1. We collected sequences of all subtypes
and aligned them against the consensus subtype B sequence
(Korber and Myers, 1992). Any sequence shorter than 99
residues was excluded, and all residues with ambiguity were
treated as gaps. A MI matrix was generated for each dataset
of HIV-1 protease sequences listed in Table 1.
The result for dataset 1 is illustrated in Figure 1. The plot
underneath represents the entropy profile, calculated using
Equation (3). Peaks are distinguished at positions such as 10,
20, 63 and 82, reflecting the high tendency of these residues to
undergo substitutions.
In order to extract more distinctive information, each MI
matrix was subjected to spectral graph bi-partitioning as
described above, and the elements were re-ordered (i.e. rows/
columns were shuffled) according to the rank of residues
indicated by the dominant eigenvector y2 (i.e. by sorting the
elements of y2 in descending order). Figure 2 displays the MI
maps as a function of the re-ordered residues for datasets
1 and 2. The exact labeling of residues following rank ordering
can be found in the Supplementary Materials. For visual
clarity, the top ranking (highest MI) pairs of amino acids (500
out of a total of 99 99 pairs) are displayed. The bar plots refer
to the entropy at each site.
Comparison of panels A and B of Figure 2 reveals that
dataset 1 (panel A) contains two distinctive clusters of
correlated residues located at the upper right and lower left
portions of the map, while dataset 2 does not contain the
2nd cluster (at the upper right) (panel B). The identity of the
residues at these two extreme ends of the maps generated for
all datasets in Table 1 can be seen in Figure 3. Here we colored
in blue and red the first and last 12 residues rank ordered
after the spectral bi-partitioning of the MI matrix for
each dataset (labeled). Interestingly, all datasets, treated with
different regimens or untreated, exhibit similar patterns, with
the two groups of residues exhibiting most distinctive correla-
tion behavior clustered at similar sequence positions.
3.2 Examination of the two distinctive clusters
Given that the respective datasets 1 and 2 refer to treated and
untreated sequences, the cluster at the top right in Figure 2A,
which does not exist in panel B, is attributed to the substitu-
tions induced by drug treatment. We will refer to these
positions as drug resistance cluster (DRC) sites.
The 2nd cluster of residues, on the other hand, is interest-
ingly found to primarily contain positions reported to exhibit
sequence variability between different viral subtype isolates
(Gonzales et al., 2001). To verify this feature, we collected 5149
untreated non-B subtype sequences from the Stanford DB,
Fig. 1. MI map (A) and entropy profile (B) for sequences in Dataset 1.
The entries in the map are calculated using Equation (1) for the 7758
sequences compiled in Dataset 1 (Table 1). The MI varies in the range
05I(X, Y)50.25, as indicated by the gray scale on the right. Panel B
displays the entropy profile, with the peaks indicating those sites
exhibiting the largest variation among the members of this dataset.
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respect to the consensus subtype B sequence (Fig. 4A). (More
detailed information on the variation for each individual non-B
subtype isolates can be found in Fig. 2 of Gonzales et al., 2001).
This suggests a phylogenetic origin for the observed covari-
ance, which can well be obtained simply based on few neutral
substitution events in the evolution of the HIV subtypes. These
residues do not necessarily possess important functional/
structural associations (Noivirt et al., 2005). We will refer to
this cluster of residues as the phylogenetic variation cluster
(PhVC).
It should be noted, however, that sequence variations
between subtypes are not necessarily functionally insignificant.
This is reflected for example by the fact that different subtypes
have different tendencies for acquisition of resistance mutations
(Kantor et al., 2005). Indeed, residues related to drug resistance
can be found in this cluster. Positions 20 and 36 exhibit
enhanced mutation rates in the presence of PIs (Wu et al., 2003,
Table 2; Hoffman et al., 2003, Fig. 1A). It is possible that the
evolution of HIV subtypes is partially related to the exposure
to natural or unnatural PIs. Residue Leu89 in the PhVC is
known, for example, as a minor drug-resistant residue (meaning
that a mutation at this position contributes to drug resistance
only in the presence of a major resistant mutation, whereas
a major resistant mutation reduces drug susceptibility by
itself; Shafer, 2002). Yet, overall, the members of the PhVC
are best characterized as those demonstrating sequence
variability between subtypes with no clear functional relation
between them.
In contrast to the PhVC, the DRCs identified for datasets 1,
3, 4 and 6 mostly contain drug-resistant mutations (Fig. 4B).
In particular, some residues belonging to these clusters
are associated with mutations involved in multi-drug cross-
resistance, such as Leu10, Met46, Ile54, Ala71, Val82, Ile84
and Leu90 (Hertogs et al., 2000; Kozal, 2004). In a previous
study (Ohtaka et al., 2003), Leu10, Met46, Ile54, Val82, Ile84
and Leu90 were shown to exert a cooperative effect in lowering
the affinity of multiple PIs. Leu10, although not causing
Fig. 2. MI maps with residues re-ordered according to spectral graph bi-clustering (A) Re-organized MI matrix for treated data (dataset 1). Two
distinctive types of correlated mutations can be seen at the lower left and upper right portions of the map. (B) Re-organized MI matrix for untreated
data (dataset 2). One of the previous clusters is observed (lower left), while the 2nd (top right) is non-existent. The latter is attributed to correlated
substitutions induced in the presence of inhibitors, while the former (upper right) refers to evolutionary changes observed between HIV-1 protease
subtypes. See Figure 3 for the identity of residues belonging to the two clusters, and the Supplementary Material for the identity of rank-ordered
residues for each dataset listed in Table 1. The bar plots refer to the sequence entropy associated with each position. Equivalent figures for the other
four datasets can be found in the Supplementary Material.
Fig. 3. Sequence position of two most distinctive clusters of residues. Results are reported for each of the six datasets listed in Table 1. The two
clusters include the two extreme subsets of 12 residues rank ordered according to the spectral bi-partitioning of the MI matrix computed for each
dataset. The DRC residues are colored blue, the residues belonging to the PhVC are colored red.
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role in eliciting the cooperative response along with Leu90
(Ohtaka et al., 2003), consistent with the high correlation
detected here among these residues in the DRC. We also note
that some major mutation sites in the DRC are not active
in MDR; or say, they are specific to one PI, like Leu24
and Asp30 (Shafer, 2002). Still, their participation in the DRC
suggests that the resistance mechanism cooperatively involves
several residues.
The DRCs for datasets 2 and 5 contain a number of sites that
depart from those shared by other datasets (Fig. 3). For dataset
2, which contains untreated isolates only, this is clear, and
even the observed level of similarity to other datasets is striking.
For dataset 5, on the other hand, the result implies that NFV
elicits unique responses at specific sites, quite different from
that of most other drugs. We note in particular that Asp30
and Asn88 exhibit extraordinarily high MI. As shown before
(Rhee et al., 2003), the double mutation D30N and N88D can
reduce nelfinavir susceptibility by 50-fold, explaining the
selection pressure for their co-variation. When NFV is used
in combination with other PIs (dataset 6), the DRC sites shared
with other datasets are observed, indicating that the coopera-
tive effect is related to cross-resistance in this case. Most of
the residues of the DRC remain unchanged in the IDV set
(dataset 3), suggesting that the correlations revealed in our
analysis are not only due to individual resistance mutations
developed against different drugs, but reflect real cooperativity.
An exhaustive search for correlated mutations among drug-
resistant sites in HIV-1 isolates was performed by Wu et al.
(2003), which yielded small groups of correlated residues,
ranging in size from three to six residues. On the other hand,
the present study yields one large cluster providing evidence for
the high cooperativity of the residues belonging to these small
groups. We also note that the presently detected positions
47 and 48 in the flap region do not appear in the study by
Wu et al. as prominent drug resistance sites, but they are known
to be major resistant mutations. Wu et al. listed other residues,
e.g. Ile62, Leu63 and Ile93, together with known drug
resistance residues. We have not detected these residues in
our DRC, and neither do they appear in the Stanford PI DB
drug resistance notes as drug-induced mutations. Note that
our study is based on a larger dataset of isolates, and a major
merit of the present work is to identify the DRC sites without
prior knowledge of drug-resistant mutation sites, while the
study of Wu et al. analyzes the mutations at 45 (out of 99)
positions that have been significantly associated with protease
inhibitor treatment.
Hoffman et al. 2003 analyzed the correlations between
31 positions in HIV-1 protease, which showed the highest
variability in their dataset of HIV-1 isolates (from 648
untreated, and 531 treated persons). These were grouped in
three clusters based on the comparison of mutation rates
between treated and untreated datasets. This criterion is
different from the one (based on MI data) adopted in our
study, but it is still tempting to compare the two sets of results.
Those residues in Class III therein are similar to those in
our DRC, while Class I resembles our phylogenetic cluster
PhVC. Notably, residues Lys20, Met36 which are part of our
phylogenetic cluster appear in cluster II and cluster III,
respectively. These residues exhibit substantial sequence varia-
bility between subtypes, and appear to be relevant to drug
resistance, but apparently not in a cooperative manner with
other residues.
3.3 k-way clustering using more eigenvectors
The results from k-way clustering of dataset 1 using k¼3, 4
and 5 are presented in Table 2. The most correlated residues
identified above take part in the same clusters, consistent with
results from bi-partitioning. Notably, Asp30 and Asn88, which
originally belonged to the DRC, exhibited a tendency to form
a separate cluster together with Val75. This triplet (Asp30,
Asn88, Val75) was also reported to form a cluster in previous
work (Wu et al., 2003). It has long been known that
Fig. 4. Comparison with experimental data. (A) Sequence variation
profile compiled from experimental data for the non-B subtype HIV
(from Stanford DB). Note the correspondence between peaks (most
variable sites) and the phylogenetic variation sites (red in the alignment)
identified in the present study. (B) Comparison with drug resistance
profile (based on data in Stanford DB http://hivdb.stanford.edu/cgi-
bin/PIResiNote.cgi). Dark blue lines refer to residues that exhibit major
drug resistance; light blue, to minor drug resistance sites.
Table 2. Results from k-way clustering
k Cluster
3 C1: 30, 75, 88
C2: 1– 9, 12–15, 17, 19, 20, 22, 25, 26, 28, 31, 35–42, 45, 49, 52,
56, 57, 59, 61, 65, 68–70, 77, 83, 87, 89, 96–99
4 C1: 1, 2, 9, 26, 30, 40, 45, 56, 59, 75, 81, 88, 98
C2: 13–15, 20, 35–38, 41, 42, 49, 57, 69, 70, 77, 83, 89
C3: 10, 23, 24, 27, 32–34, 43, 46–48, 50, 53–55, 58, 71, 76, 80, 82
5 C1: 30, 75, 88
C2: 1, 2, 9, 26, 40, 45, 59, 87, 98
C3: 13–15, 20, 35–38, 41, 49, 57, 69, 70, 77, 83, 89
C4: 10, 23, 24, 27, 32–34, 42, 43, 46–48, 50, 53–55, 58, 71,76, 80, 82
For clarity, the largest cluster that includes all the remaining residues in each case,
is not shown.
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reducing the susceptibility of nelfinavir; however, little atten-
tion has been given to date to their possible association with
Val75. As indicated in Figure 5, the high correlation of Val75
with Asp30 and Asn88 (Fig. 5A), consistent with their struc-
tural proximity (Fig. 5B), may originate from a cooperative
mechanism for drug resistance between these three sites.
3.4 Interpretation with respect to protein dynamics
The examination of HIV-1 protease 3D-structure reveals that
the residues participating in the DRC tend to occupy the flap
region (Met46, Ile47, Ile54), the close neighborhood of the
active site (Asp30, Val32, Val82, Ile84), and the dimerization
interface (Leu10, Leu90). Most of PhVC residues, on the other
hand, are located away from the interface, toward the exterior
of the protein (Fig. 6A). Interestingly, both groups of residues
assume regular secondary structures (helices or strands),
although their relative positions with respect to the interfacial
region differs.
We also examined the distance separation between the closest
atoms of residue pairs belonging to the two clusters. Table S2
in the Supplementary Material lists the distances between top-
ranking residue pairs in the two clusters (corresponding to the
lower left and upper right of the MI map in Fig. 2A). For each
pair two values have been considered: intra-molecular (mono-
mers A–A or B–B contacts) or intermolecular (A–B contacts).
The distances between the closest atoms for each case are
listed. These data clearly demonstrate that the correlated
pairs essentially refer to intra-molecular interactions, rather
than inter-molecular. Note that the MI method cannot detect
the correlations between the fully conserved residues at the
interface between the monomers (e.g. P1-F99 and D29-R8).
A further comparison between the results from CMA and
the mobilities of residues predicted by the GNM (Bahar et al.,
1997) elucidates the close correspondence between the global
dynamics of the enzyme and its function. The lowest frequency
GNM mode usually defines the global dynamics of the enzyme
accessible under native state conditions, and such cooperative
motions intrinsically favored by the structure have been
shown to relate to enzymatic function (Yang and Bahar,
2005). In particular, the global hinge regions (minima in the
mobility profiles driven by global modes) play a critical role
in conferring the mechanical properties of enzymes that
complement their chemical (catalytic) activities.
Fig. 6. Comparison of results from CMA and GNM dynamics. (A) The location of the two clusters identified for dataset 1 on the 3D-structure
of HIV-1 protease. The DRC is colored blue, and the PVC is colored red. We displayed the residues that have appeared at least three times (out of
six examined datasets) in the same cluster in Figure 3. (B) Ribbon diagram color-coded after the mobilities of residues in the first slow mode
predicted by the GNM. The residue mobility increases from blue to red. (C) GNM slow-mode profile as a function of residue index. Note that
calculations are performed for the dimer, but results are shown for a monomer, the curves for the two monomers being identical. The HIV-1 protease
mutant bound with IDV (PDB id: 2B7Z) was used. Ribbon diagrams were made with PyMOL (http://www.pymol.org).
Fig. 5. (A) The MI profile of Val75 with other residues in the treated
dataset (dataset1). (B) The structural vicinity of Asp30, Asn88 and
Val75. The figure was made with PyMOL (http://www.pymol.org).
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the DRCs and PhVCs, we performed GNM calculation for
an HIV-1 protease mutant bound to IDV (PDB file 2B7Z).
This structure contains 10 mutations, most of which belong
to the DRC presently identified for the IDV-treated dataset.
The color-coded ribbon diagram in panel B of Figure 6,
and the slow-mode profile in panel C, display the mobilities
in the lowest frequency mode predicted by the GNM for this
structure. Comparison of panels A and B shows that the
DRC residues tend to occupy positions that are highly con-
strained in the global mode, whereas PhVC residues are located
at relatively flexible positions. These distinctive dynamics of
the two groups of residues explains the fact that the PhVCs
are accommodated without altering the structure and func-
tion; whereas mutations at the DRC sites that are more
buried and spatially constrained have functional consequences.
Calculations repeated for the substrate-bound complex (PDB
id: 2FNS) confirmed that the slow-mode profile is insensitive
to structural asymmetry and yielded the almost identi-
cal profiles for the two subunits, while the 2nd mode exhib-
ited a stronger dependence on structural asymmetry (see
Supplementary Material).
Finally, we compare the global mobility profile (panel C)
with the sequence position of the two clusters (Fig. 3)
reproduced in Figure 6 to ease the visual comparison. The
residues in the DRC are seen to usually lie close to global hinge
regions (minima), while those in the PhVC are distributed in
high mobility regions. Calculations were repeated for the 2nd
and 3rd GNM modes as well. Comparison of the minima and
maxima in these modes with the PhVC (red) and DRC (blue)
sites along the sequence shows that PhVC modes exhibit
relatively high mobilities in modes 2 and/or 3 as well, whereas
the confinement of DRC residues to hinge sites is characteristic
of the first (global) mode. The DRC residues located at the
flap region (residues 46–54) show a high mobility in modes 2
and 3. See the Supplementary Material for the counterpart of
Figure 6C for these two modes. Co-localization of MDR sites
with global hinge regions thus emerges as an effective means
of impacting the cooperative dynamics, and hence the function
of the enzyme (Bahar et al., 1998) and on the catalysis.
4 CONCLUSION
In the present study, we analyzed the covariance patterns in
HIV-1 protease sequences using a simple metric, MI, followed
by spectral clustering. The approach proved to discriminate
between two groups of correlated mutation sites, shortly
referred to as DRC and PhVC. Mutations in the DRC tend
to confer MDR while those in the PhVC seem to differentiate
between different HIV-1 protease subtypes. We have further
explored the biophysical basis of the observed differences
between the two clusters of correlated sites. The two clusters
were found to significantly differ with regard to their role in
the intrinsic structural dynamics of the enzyme. The DRC sites
select key mechanical regions, near the global hinges that
control the most cooperative motions of the enzyme; PhVC
residues, on the other hand, preferentially occupy flexible
regions that can easily accommodate residue substitutions.
Covariance analysis of related protein sequences is known
to be problematic in many aspects (Fodor and Aldrich, 2004;
Halperin et al., 2006). Many options exist to improve the basic
method presented here. For example, MI treats all substitutions
of amino acids equally, ignoring physicochemical preferences.
In the future, it may be worth considering different essential
covariance measures for further analysis. Methods for assigning
significant scores using the original MI scores and shuffling
of the original data (Hoffman et al., 2003; Shackelford and
Karplus, 2007) can also help in obtaining more meaningful
results.
One major goal here was, however, to draw attention to the
utility of clustering the covariance data. We utilized a relatively
less detailed, but objective and theoretically robust approach.
Significantly, this approach allowed us to separate the sequence
covariance arising from functional pressures (e.g. MDR) from
those evolutionarily selected within the examined phylogeny.
Both groups of correlations exhibit strong signals when
covariance properties are quantified in terms of MI. Yet, the
distinctive character of the two groups, confirmed by experi-
ments (Fig. 4), and rationalized by comparison with struc-
tural dynamics (Fig. 6), supports the utility of adopting a
spectral bi-clustering method for efficiently discriminating
between potential correlations of fundamentally different
nature/origin. It will be of interest to further explore the
utility of spectral bi-clustering for differentiating between
correlated mutations that reflect ‘real’ inter-residue inter-
actions and those reflecting other evolutionary signals, often
considered as noise for most analyses purposes (Noivirt et al.,
2005).
Notably, some of the sites for potential MDR, indistinguish-
able in the untreated sequences (Fig. 2B), can be detected upon
rank ordering the residues via spectral clustering of MI data;
furthermore, treated sequences subjected to different regimens
share common DRC residues (Fig. 3). These two observations
invite attention to the intrinsic tendency of the enzyme to
potentially select those effective sites to develop mutations that
confer MDR, irrespective of treatment.
A challenging, yet important task, which is a natural conti-
nuation to this work, is to detect correlations between protease
residues and residues of other mature/pre-mature proteins of
HIV-1. A recent work demonstrates how such correlations
can be detected between a protease mutation (V82A) and a
mutation at the nucleocapsid-p1 cleavage site (Prabu-Jeyabalan
et al., 2004). It remains to be seen if current methodology can
be extended to investigating the relation between the protease
and other cleavage sites as well as the correlations with other
regions in HIV-1 pre-proteins, toward shedding more light on
the late stages of the virus maturation.
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